Venus Concept Inc. to Participate in the Stifel 2021 Virtual Healthcare Conference

Rhea-AI Summary

Venus Concept, a leader in medical aesthetic technology, announces management's participation in the Stifel 2021 Virtual Healthcare Conference on November 17th at 4:00 p.m. ET. An audio webcast of the session will be available on their investor relations website, and a replay will follow the event. The company operates in over 60 countries, focusing on a subscription-based model for its diverse product portfolio, which includes devices for aesthetic procedures and hair restoration systems like NeoGraft and ARTAS.

TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2021 Virtual Healthcare Conference.

Management will participate in a fireside chat at the conference on Wednesday, November 17th at 4:00 p.m. Eastern Time.

An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 18 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

What is Venus Concept's participation in the Stifel 2021 Virtual Healthcare Conference?

Venus Concept will participate in a fireside chat at the conference on November 17th at 4:00 p.m. ET.

How can I access the audio webcast of Venus Concept's conference presentation?

The audio webcast can be accessed under the 'Events' section of Venus Concept's investor relations website.

What products does Venus Concept offer?

Venus Concept offers a range of minimally invasive and non-invasive medical aesthetic technologies, including devices like Venus Versa and hair restoration systems like NeoGraft.

In how many countries does Venus Concept operate?

Venus Concept operates in over 60 countries worldwide.

What is the business model of Venus Concept?

Venus Concept focuses on a subscription-based sales strategy in North America and its global markets.